An ambiguous phenomenon of radiation and drugs: Recall reactions

Basit Öğe Kaydı
dc.authoridCosar, Rusen/0000-0002-7953-8887
dc.authoridCosar, Rusen/0000-0002-7953-8887
dc.authorwosidCosar, Rusen/AAC-4045-2020
dc.authorwosidCosar, Rusen/GQP-7875-2022
dc.contributor.authorCaloglu, Murat
dc.contributor.authorYurut-Caloglu, Vuslat
dc.contributor.authorCosar-Alas, Rusen
dc.contributor.authorSaynak, Mert
dc.contributor.authorKaragol, Hakan
dc.contributor.authorUzal, Cem
dc.date.accessioned2024-06-12T11:13:25Z
dc.date.available2024-06-12T11:13:25Z
dc.date.issued2007
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe term 'radiation recall' describes an acute inflammatory reaction in previously irradiated areas after the administration of certain inciting systemic agents. It was first described in 1959 by D'Angio that dermatitis is related to the application of actinomycin D on the skin. Though this reaction occurs frequently on the skin, it may also be seen in the oral mucosa, the larynx, esophagus, small intestine, lungs, muscle tissue, and brain. Most drugs associated with recall reactions are cytotoxics, however, several other drugs may also elicit the phenomenon. Although this phenomenon is well known, its etiology is not understood. Radiation recall reactions are generally associated with megavoltage radiotherapy. The time interval between the completion of radiotherapy and the recall reaction ranges from days to years. The recall reaction occurs on average 8 days (3 days to 2 months) after the application of the promoting agent. Although no standard treatment exists, some authors suggest discontinuation of the inciting drug and the use of corticosteroids or nonsteroidal anti-inflammatory agents.en_US
dc.identifier.doi10.1159/000099632
dc.identifier.endpage214en_US
dc.identifier.issn0378-584X
dc.identifier.issn1423-0240
dc.identifier.issue4en_US
dc.identifier.pmid17396045en_US
dc.identifier.scopus2-s2.0-33947598102en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage209en_US
dc.identifier.urihttps://doi.org/10.1159/000099632
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23547
dc.identifier.volume30en_US
dc.identifier.wosWOS:000245139500008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofOnkologieen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRecall Reactionsen_US
dc.subjectDermatitisen_US
dc.subjectRadiotherapyen_US
dc.subjectChemotherapyen_US
dc.subjectMetastatic Osteogenic Sarcomaen_US
dc.subjectImmune-Deficiency-Syndromeen_US
dc.subjectActinomycin-Den_US
dc.subjectDermatitisen_US
dc.subjectAdriamycinen_US
dc.subjectTherapyen_US
dc.subjectGemcitabineen_US
dc.subjectPatienten_US
dc.subjectComplicationsen_US
dc.subjectChemotherapyen_US
dc.titleAn ambiguous phenomenon of radiation and drugs: Recall reactionsen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu